Pacira Pharmaceuticals (PCRX) Q2 results: Revenues: $102.6M (+22.0%); Exparel sales: $98.9M (+23.0%); Iovera: $2M; Royalty revenue: $0.8M (+100.0%).
Net Income: $2.7M (+3.8%); EPS: $0.06 (unch); Non-GAAP Net Income: $17.5M (+76.8%); Non-GAAP EPS: $0.41 (+70.8%).
2019 Guidance: Exparel net product sales: $400M – 410M (unch); iovera net product sales: $8M – 10M (unch).
Shares are up 4% premarket.
Previously: Pacira Pharmaceuticals EPS beats by $0.07, beats on revenue(Aug. 8)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.